SEVEN EIGHT CAPITAL, LP - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2017. The put-call ratio across all filers is 1.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2020$704,000
+82.4%
18,941
+117.5%
0.15%
+560.9%
Q3 2018$386,000
-55.8%
8,707
-61.0%
0.02%
-62.3%
Q2 2018$874,000
-25.5%
22,307
-4.7%
0.06%
-57.3%
Q3 2017$1,173,000
+1264.0%
23,398
+1153.2%
0.14%
+1091.7%
Q2 2017$86,000
-73.5%
1,867
-46.7%
0.01%
-97.8%
Q1 2015$324,0003,5000.54%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2017
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$27,840,84218.82%
Ikarian Capital, LLC 1,891,147$11,781,8462.84%
Altium Capital Management LP 620,000$3,862,6001.96%
Ikarian Capital, LLC 1,296,900$8,079,6871.95%
Parkman Healthcare Partners LLC 822,784$5,125,9441.36%
Deep Track Capital, LP 4,000,000$24,920,0001.05%
Monaco Asset Management SAM 470,100$2,928,7230.88%
BRAIDWELL LP 3,393,405$21,140,9130.71%
Telemetry Investments, L.L.C. 71,000$4420.70%
Rhenman & Partners Asset Management AB 900,000$5,607,0000.58%
View complete list of ESPERION THERAPEUTICS INC NE shareholders